Eintrag weiter verarbeiten
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules
Gespeichert in:
| Zeitschriftentitel: | Annals of Oncology |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , , , , , , , , |
| In: | Annals of Oncology, 25, 2014, S. v1 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Elsevier BV
|
| Schlagwörter: |
| author_facet |
Robert, C. Joshua, A.M. Weber, J.S. Ribas, A. Hodi, F.S. Kefford, R.F. Daud, A. Wolchok, J.D. Hwu, W-J. Gangadhar, T.C. Patnaik, A. Hersey, P. Dronca, R. Zarour, H. Ge, Y. Lindia, J.A. Giannotti, M. Ebbinghaus, S. Kang, S.P. Hamid, O. Robert, C. Joshua, A.M. Weber, J.S. Ribas, A. Hodi, F.S. Kefford, R.F. Daud, A. Wolchok, J.D. Hwu, W-J. Gangadhar, T.C. Patnaik, A. Hersey, P. Dronca, R. Zarour, H. Ge, Y. Lindia, J.A. Giannotti, M. Ebbinghaus, S. Kang, S.P. Hamid, O. |
|---|---|
| author |
Robert, C. Joshua, A.M. Weber, J.S. Ribas, A. Hodi, F.S. Kefford, R.F. Daud, A. Wolchok, J.D. Hwu, W-J. Gangadhar, T.C. Patnaik, A. Hersey, P. Dronca, R. Zarour, H. Ge, Y. Lindia, J.A. Giannotti, M. Ebbinghaus, S. Kang, S.P. Hamid, O. |
| spellingShingle |
Robert, C. Joshua, A.M. Weber, J.S. Ribas, A. Hodi, F.S. Kefford, R.F. Daud, A. Wolchok, J.D. Hwu, W-J. Gangadhar, T.C. Patnaik, A. Hersey, P. Dronca, R. Zarour, H. Ge, Y. Lindia, J.A. Giannotti, M. Ebbinghaus, S. Kang, S.P. Hamid, O. Annals of Oncology Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules Oncology Hematology |
| author_sort |
robert, c. |
| spelling |
Robert, C. Joshua, A.M. Weber, J.S. Ribas, A. Hodi, F.S. Kefford, R.F. Daud, A. Wolchok, J.D. Hwu, W-J. Gangadhar, T.C. Patnaik, A. Hersey, P. Dronca, R. Zarour, H. Ge, Y. Lindia, J.A. Giannotti, M. Ebbinghaus, S. Kang, S.P. Hamid, O. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdu438.42 Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules Annals of Oncology |
| doi_str_mv |
10.1093/annonc/mdu438.42 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR1NDM4LjQy |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR1NDM4LjQy |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
Elsevier BV, 2014 |
| imprint_str_mv |
Elsevier BV, 2014 |
| issn |
0923-7534 |
| issn_str_mv |
0923-7534 |
| language |
English |
| mega_collection |
Elsevier BV (CrossRef) |
| match_str |
robert2014pembrolizumabpembromk3475foradvancedmelanomamelrandomizedcomparisonoftwodosingschedules |
| publishDateSort |
2014 |
| publisher |
Elsevier BV |
| recordtype |
ai |
| record_format |
ai |
| series |
Annals of Oncology |
| source_id |
49 |
| title |
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_unstemmed |
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_full |
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_fullStr |
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_full_unstemmed |
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_short |
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_sort |
pembrolizumab (pembro; mk-3475) for advanced melanoma (mel): randomized comparison of two dosing schedules |
| topic |
Oncology Hematology |
| url |
http://dx.doi.org/10.1093/annonc/mdu438.42 |
| publishDate |
2014 |
| physical |
v1 |
| description |
|
| container_start_page |
0 |
| container_title |
Annals of Oncology |
| container_volume |
25 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792332813339459593 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:02:50.098Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Pembrolizumab+%28Pembro%3B+Mk-3475%29+for+Advanced+Melanoma+%28Mel%29%3A+Randomized+Comparison+of+Two+Dosing+Schedules&rft.date=2014-09-01&genre=article&issn=0923-7534&volume=25&pages=v1&jtitle=Annals+of+Oncology&atitle=Pembrolizumab+%28Pembro%3B+Mk-3475%29+for+Advanced+Melanoma+%28Mel%29%3A+Randomized+Comparison+of+Two+Dosing+Schedules&aulast=Hamid&aufirst=O.&rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdu438.42&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792332813339459593 |
| author | Robert, C., Joshua, A.M., Weber, J.S., Ribas, A., Hodi, F.S., Kefford, R.F., Daud, A., Wolchok, J.D., Hwu, W-J., Gangadhar, T.C., Patnaik, A., Hersey, P., Dronca, R., Zarour, H., Ge, Y., Lindia, J.A., Giannotti, M., Ebbinghaus, S., Kang, S.P., Hamid, O. |
| author_facet | Robert, C., Joshua, A.M., Weber, J.S., Ribas, A., Hodi, F.S., Kefford, R.F., Daud, A., Wolchok, J.D., Hwu, W-J., Gangadhar, T.C., Patnaik, A., Hersey, P., Dronca, R., Zarour, H., Ge, Y., Lindia, J.A., Giannotti, M., Ebbinghaus, S., Kang, S.P., Hamid, O., Robert, C., Joshua, A.M., Weber, J.S., Ribas, A., Hodi, F.S., Kefford, R.F., Daud, A., Wolchok, J.D., Hwu, W-J., Gangadhar, T.C., Patnaik, A., Hersey, P., Dronca, R., Zarour, H., Ge, Y., Lindia, J.A., Giannotti, M., Ebbinghaus, S., Kang, S.P., Hamid, O. |
| author_sort | robert, c. |
| container_start_page | 0 |
| container_title | Annals of Oncology |
| container_volume | 25 |
| description | |
| doi_str_mv | 10.1093/annonc/mdu438.42 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR1NDM4LjQy |
| imprint | Elsevier BV, 2014 |
| imprint_str_mv | Elsevier BV, 2014 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 0923-7534 |
| issn_str_mv | 0923-7534 |
| language | English |
| last_indexed | 2024-03-01T14:02:50.098Z |
| match_str | robert2014pembrolizumabpembromk3475foradvancedmelanomamelrandomizedcomparisonoftwodosingschedules |
| mega_collection | Elsevier BV (CrossRef) |
| physical | v1 |
| publishDate | 2014 |
| publishDateSort | 2014 |
| publisher | Elsevier BV |
| record_format | ai |
| recordtype | ai |
| series | Annals of Oncology |
| source_id | 49 |
| spelling | Robert, C. Joshua, A.M. Weber, J.S. Ribas, A. Hodi, F.S. Kefford, R.F. Daud, A. Wolchok, J.D. Hwu, W-J. Gangadhar, T.C. Patnaik, A. Hersey, P. Dronca, R. Zarour, H. Ge, Y. Lindia, J.A. Giannotti, M. Ebbinghaus, S. Kang, S.P. Hamid, O. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdu438.42 Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules Annals of Oncology |
| spellingShingle | Robert, C., Joshua, A.M., Weber, J.S., Ribas, A., Hodi, F.S., Kefford, R.F., Daud, A., Wolchok, J.D., Hwu, W-J., Gangadhar, T.C., Patnaik, A., Hersey, P., Dronca, R., Zarour, H., Ge, Y., Lindia, J.A., Giannotti, M., Ebbinghaus, S., Kang, S.P., Hamid, O., Annals of Oncology, Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules, Oncology, Hematology |
| title | Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_full | Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_fullStr | Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_full_unstemmed | Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_short | Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| title_sort | pembrolizumab (pembro; mk-3475) for advanced melanoma (mel): randomized comparison of two dosing schedules |
| title_unstemmed | Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules |
| topic | Oncology, Hematology |
| url | http://dx.doi.org/10.1093/annonc/mdu438.42 |